Korea Health Industry Development Institute has recently announced the business strategy of Korean new drug development

Published: 2014-04-07 14:13:45

Updated: 2014-04-07 14:13:45

Korea Health Industry Development Institute has recently announced the business strategy of Korean new drug development through report of "Trends and prospects of new drug re-creation in major advanced country".

According to the report, global pharmaceutical industries including South Korea increase R & D investment, but the success rate is still low. R & D expenses per 1 new drug sored from $...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.